Your browser doesn't support javascript.
loading
Improving COVID-19 critical care mortality over time in England: A national cohort study, March to June 2020
John Dennis; Andrew McGovern; Sebastian Vollmer; Bilal A Mateen.
Affiliation
  • John Dennis; University of Exeter
  • Andrew McGovern; University of Exeter
  • Sebastian Vollmer; University of Warwick
  • Bilal A Mateen; The Alan Turing Institute
Preprint in En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20165134
ABSTRACT
ObjectivesTo determine the trend in mortality risk over time in people with severe COVID-19 requiring critical care (high intensive unit [HDU] or intensive care unit [ICU]) management. MethodsWe accessed national English data on all adult COVID-19 specific critical care admissions from the COVID-19 Hospitalisation in England Surveillance System (CHESS), up to the 29th June 2020 (n=14,958). The study period was 1st March until 30th May, meaning every patient had 30 days of potential follow-up available. The primary outcome was in-hospital 30-day all-cause mortality. Hazard ratios for mortality were estimated for those admitted each week using a Cox proportional hazards models, adjusting for age (non-linear restricted cubic spline), sex, ethnicity, comorbidities, and geographical region. Results30-day mortality peaked for people admitted to critical care in early April (peak 29.1% for HDU, 41.5% for ICU). There was subsequently a sustained decrease in mortality risk until the end of the study period. As a linear trend from the first week of April, adjusted mortality risk decreased by 11.2% (adjusted HR 0.89 [95% CI 0.87 - 0.91]) per week in HDU, and 9.0% (adjusted HR 0.91 [95% CI 0.88 - 0.94]) in ICU. ConclusionsThere has been a substantial mortality improvement in people admitted to critical care with COVID-19 in England, with markedly lower mortality in people admitted in mid-April and May compared to earlier in the pandemic. This trend remains after adjustment for patient demographics and comorbidities suggesting this improvement is not due to changing patient characteristics. Possible causes include the introduction of effective treatments as part of clinical trials and a falling critical care burden.
License
cc_by
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Cohort_studies / Observational_studies / Prognostic_studies Language: En Year: 2020 Document type: Preprint
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Cohort_studies / Observational_studies / Prognostic_studies Language: En Year: 2020 Document type: Preprint